Publications by authors named "D M Kecmanovic"
Mucinous ovarian cancer occurs sporadically, with a frequency of approximately 3-5% among all subtypes of ovarian cancer. Extreme leukocytosis >40,000 and 50,000 has been described in most solid tumors and is associated with a poor prognosis, although there is a lack of literal data of its occurrence after cytoreductive surgery and HIPEC in the treatment of advanced mucinous ovarian cancer. There is higher risk of the occurrence of cholecystitis in oncology patients compared to the general population, although there is no formal evidence for this, and the association with ovarian cancer is accompanied by a relative risk of 1.
View Article and Find Full Text PDFArticle Synopsis
- Advanced epithelial ovarian cancer (EOC) has poor prognosis, but a study examines outcomes of patients undergoing cytoreductive surgery combined with intraperitoneal chemotherapy (HIPEC or EPIC).
- From 1995 to 2014, 116 patients were treated, revealing longer median survival for primary EOC (41.3 months) compared to recurrent EOC (27.3 months), with survival rates dropping significantly over 3 and 5 years.
- Key findings highlight that lower peritoneal cancer index (PCI) scores showed better survival rates, and both PCI and the timing of treatment (primary vs. recurrent) were important predictors of patient outcomes.
Background And Aims: The aim of this study was to compare the feasibility and early postoperative outcomes between patients undergoing double-barreled wet colostomy and patients undergoing terminal colostomy and ileal conduit for simultaneous urinary and fecal diversion.
Material And Methods: Between 1995 and 2012, we had 181 patients in whom it was necessary to make simultaneous urinary and fecal diversion. This is a retrospective study and patients were divided into two groups, depending on the technique applied for the fecal and urinary diversion.